Terms: = Leukemia AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
360 results:
1. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract] [Full Text] [Related]
2. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
[TBL] [Abstract] [Full Text] [Related]
3. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
Murdock HM; Ho VT; Garcia JS
Front Immunol; 2024; 15():1359113. PubMed ID: 38571944
[TBL] [Abstract] [Full Text] [Related]
4. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
[TBL] [Abstract] [Full Text] [Related]
5. m
Wen Q; Wang S; Hong L; Shen S; He Y; Sheng X; Zhuang X; Chen S; Wang Y; Zhuang H
Immun Inflamm Dis; 2024 Jan; 12(1):e1150. PubMed ID: 38270308
[TBL] [Abstract] [Full Text] [Related]
6. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid leukemia.
Zhai Y; Shen H; Wei H
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
[TBL] [Abstract] [Full Text] [Related]
7. Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients.
Solé L; Lobo-Jarne T; Cabré-Romans JJ; González A; Fernández L; Marruecos L; Guix M; Cuatrecasas M; López S; Bellosillo B; Torres F; Iglesias M; Bigas A; Espinosa L
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119658. PubMed ID: 38216091
[TBL] [Abstract] [Full Text] [Related]
8. Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid leukemia.
Cheng Y; Yang X; Wang Y; Li Q; Chen W; Dai R; Zhang C
BMC Med Inform Decis Mak; 2024 Jan; 24(1):2. PubMed ID: 38167056
[TBL] [Abstract] [Full Text] [Related]
9. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.
Pan B; Xu Z; Du K; Gao R; Zhang J; Yin H; Shen H; Liang J; Li Y; Wang L; Li J; Xu W; Wu J
Ann Hematol; 2024 Apr; 103(4):1241-1254. PubMed ID: 38150112
[TBL] [Abstract] [Full Text] [Related]
10.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract] [Full Text] [Related]
11. [Immunophenotypic and Clinical Characteristics of
Liu SY; Zhu L; Wang CY; He C; Yi SJ; Meng L; Xiao M; Mao X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1639-1646. PubMed ID: 38071040
[TBL] [Abstract] [Full Text] [Related]
12. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
[TBL] [Abstract] [Full Text] [Related]
13. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
14. CALM3 affects the prognosis of leukemia and hemorrhoids.
He J; Ni Z; Li Z
Medicine (Baltimore); 2023 Nov; 102(44):e36027. PubMed ID: 37932969
[TBL] [Abstract] [Full Text] [Related]
15. The Expression and Activation of the NF-κB Pathway Correlate with Methotrexate Resistance and Cell Proliferation in Acute Lymphoblastic leukemia.
Canevarolo RR; Cury NM; Yunes JA
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895229
[TBL] [Abstract] [Full Text] [Related]
16. set-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
Di Mambro A; Arroyo-Berdugo Y; Fioretti T; Randles M; Cozzuto L; Rajeeve V; Cevenini A; Austin MJ; Esposito G; Ponomarenko J; Lucas CM; Cutillas P; Gribben J; Williams O; Calle Y; Patel B; Esposito MT
Oncogene; 2023 Dec; 42(50):3670-3683. PubMed ID: 37891368
[TBL] [Abstract] [Full Text] [Related]
17. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes.
Zhang F; Du H; Hu C; Song Y
Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405
[TBL] [Abstract] [Full Text] [Related]
18. Unusual Presentation of
Menchits Y; Salimova T; Komkov A; Abramov D; Konyukhova T; Abasov R; Raykina E; Itov A; Gaskova M; Borkovskaia A; Kazakova A; Soldatkina O; Kashpor S; Semchenkova A; Popov A; Novichkova G; Olshanskaya Y; Maschan A; Zerkalenkova E
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833906
[TBL] [Abstract] [Full Text] [Related]
19. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract] [Full Text] [Related]
20. The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia.
Liao C; Nie J; Xu XJ; Zhang JY; Xu WQ; Song H; Shen HP; Shen DY; Zhao FY; Liang J; Miao J; Tang YM
Leuk Lymphoma; 2024 Jan; 65(1):91-99. PubMed ID: 37820046
[TBL] [Abstract] [Full Text] [Related]
[Next]
